M. Baumann

发表

Concept for individualized patient allocation: ReCompare—remote comparison of particle and photon treatment plans

A. Lühr, S. Löck, Klaus Roth, 2014, Radiation Oncology.

2D and 3D convolutional neural networks for outcome modelling of locally advanced head and neck squamous cell carcinoma

Sebastian Starke, Steffen Löck, Mechthild Krause, 2020, Scientific Reports.

CT imaging during treatment improves radiomic models for patients with locally advanced head and neck cancer.

Steffen Löck, Mechthild Krause, Michael Baumann, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer.

Michael Baumann, Rosalind Perrin, Daniel Zips, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Increased evidence for the prognostic value of primary tumor asphericity in pretherapeutic FDG PET for risk stratification in patients with head and neck cancer

I. Apostolova, I. Steffen, F. Wedel, 2015, European Journal of Nuclear Medicine and Molecular Imaging.

Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy

V. Budach, J. Debus, A. Abdollahi, 2020, The pharmacogenomics journal.

Individualization of cancer treatment from radiotherapy perspective

Mechthild Krause, Michael Baumann, Ala Yaromina, 2012, Molecular oncology.

Radiation oncology in the era of precision medicine

Mechthild Krause, Michael Baumann, Christian Richter, 2016, Nature Reviews Cancer.

Exploring the role of cancer stem cells in radioresistance

M. Krause, M. Baumann, R. Hill, 2008, Nature Reviews Cancer.

Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies.

M. Krause, M. Baumann, H. Thames, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiogenomics: radiobiology enters the era of big data and team science.

Andre Dekker, Michael Baumann, Karin Haustermans, 2014, International journal of radiation oncology, biology, physics.

Creating a data exchange strategy for radiotherapy research: Towards federated databases and anonymised public datasets

Andre Dekker, Uwe Just, Mechthild Krause, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Immunohistochemically Detected p53 Mutations in Epithelial Tumors and Results of Treatment with Chemotherapy and Radiotherapy A Treatment-Specific Overview of the Clinical Data

M. Baumann, H. Thames, C. Nieder, 2002, Strahlentherapie und Onkologie.

Four decades with ESTRO.

M. Baumann, J. Overgaard, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Subjugation of TGFβ Signaling by Human Papilloma Virus in Head and Neck Squamous Cell Carcinoma Shifts DNA Repair from Homologous Recombination to Alternative End-Joining

J. Murnane, M. Baumann, M. Barcellos-Hoff, 2018, bioRxiv.

Towards genetic prediction of radiation responses: ESTRO's GENEPI project.

Michael Baumann, Tobias Hölscher, M. Baumann, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Combined tumor plus nontumor interim FDG‐PET parameters are prognostic for response to chemoradiation in squamous cell esophageal cancer

H. Amthauer, F. Hofheinz, M. Krause, 2020, International journal of cancer.

Prognostic Value of Standardized Uptake Ratio in Patients with Trimodality Treatment of Locally Advanced Esophageal Carcinoma

Michael Baumann, Frank Hofheinz, Jörg Kotzerke, 2018, The Journal of Nuclear Medicine.

An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET

I. Apostolova, I. Steffen, H. Amthauer, 2016, EJNMMI Research.

Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma

F. Hofheinz, J. van den Hoff, S. Löck, 2015, The Journal of Nuclear Medicine.

Two or four hour ( 18 F)FMISO-PET in HNSCC is the contrast best?

J. Steinbach, M. Baumann, D. Zips, 2011 .

Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?

Wolfgang Enghardt, Michael Baumann, Daniel Zips, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure

J. Steinbach, M. Krause, M. Baumann, 2015, Acta oncologica.

Two or four hour [¹⁸F]FMISO-PET in HNSCC. When is the contrast best?

J. Steinbach, M. Baumann, D. Zips, 2010, Nuklearmedizin. Nuclear medicine.

Two or four hour [18F]FMISO-PET in HNSCC

J. Steinbach, M. Baumann, D. Zips, 2011, Nuklearmedizin.

Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis

S. Löck, M. Krause, M. Baumann, 2019, Acta oncologica.

The clinical target volume in lung, head-and-neck, and esophageal cancer: Lessons from pathological measurement and recurrence analysis

Michael Baumann, Thomas Bortfeld, Esther G.C. Troost, 2017, Clinical and translational radiation oncology.

Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC

I. Tinhofer, S. Leger, S. Löck, 2020, Cancers.

HPV in

V. Budach, J. Debus, A. Abdollahi, 2014 .

PINCH1 regulates Akt1 activation and enhances radioresistance by inhibiting PP1alpha.

C. Pilarsky, A. Shevchenko, M. Baumann, 2010, The Journal of clinical investigation.

Expressing cytotoxic compounds in Escherichia coli Nissle 1917 for tumor-targeting therapy.

A. Stewart, M. Baumann, D. Zips, 2019, Research in microbiology.

Flow cytometric cell‐based assay to preselect antibody constructs for radionuclide conjugation

J. Steinbach, M. Baumann, Jan-Martin Heldt, 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging.

J. Steinbach, S. Löck, M. Krause, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Application of organ tolerance dose-constraints in clinical studies in radiation oncology

M. Baumann, W. Dörr, T. Herrmann, 2014, Strahlentherapie und Onkologie.

Radiobiological hypoxia, oxygen tension, interstitial fluid pressure and relative viable tumour area in two human squamous cell carcinomas in nude mice during fractionated radiotherapy.

B. Beuthien-Baumann, W. Enghardt, M. Baumann, 2001 .

The extreme radiosensitivity of the squamous cell carcinoma SKX is due to a defect in double-strand break repair.

M. Krause, M. Baumann, J. Dahm-Daphi, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

In Vivo Verification of Electron Beam Energy by Patient Exit Dose and Optical Density of Portal Films

M. Baumann, W. Baus, P. Geyer, 2004, Strahlentherapie und Onkologie.

Portal Verification of High-Energy Electron Beams Using their Photon Contamination by Film-Cassette Systems

M. Baumann, W. Baus, P. Geyer, 2006, Strahlentherapie und Onkologie.

Effect of [(18)F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice.

J. Steinbach, B. Beuthien-Baumann, M. Krause, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cancer Stem Cells: Targets and Potential Biomarkers for Radiotherapy

M. Krause, M. Baumann, A. Yaromina, 2011, Clinical Cancer Research.

Prognostic Value of Radiobiological Hypoxia during Fractionated Irradiation for Local Tumor Control

M. Baumann, H. Thames, D. Zips, 2011, Strahlentherapie und Onkologie.

Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiation.

M. Baumann, H. Thames, D. Zips, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cancer stem cells and radiotherapy

K. Trott, M. Krause, M. Baumann, 2009, International journal of radiation biology.

Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?

M. Krause, M. Baumann, H. Thames, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

In vivo radiation sensitivity of glioblastoma multiforme.

A. Taghian, M. Baumann, H. Suit, 1995, International journal of radiation oncology, biology, physics.

Response of xenografts of human malignant gliomas and squamous cell carcinomas to fractionated irradiation.

M. Baumann, A. Pu, H. Suit, 1992, International journal of radiation oncology, biology, physics.

Establishing the Role of Protons for Routine Clinical Practice : Health Technology Assessment and Clinical Trials

M. Baumann, D. Zips, 2013 .

Prostatakarzinom: Palliative Therapie

M. Wirth, M. Baumann, J. Kotzerke, 2016 .

Ex vivo γH2AX radiation sensitivity assay in prostate cancer: Inter-patient and intra-patient heterogeneity.

M. Baumann, H. Thames, D. Zips, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

γH2AX assay in ex vivo irradiated tumour specimens: A novel method to determine tumour radiation sensitivity in patient-derived material.

M. Krause, M. Baumann, H. Thames, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Residual γH2AX foci after ex vivo irradiation of patient samples with known tumour-type specific differences in radio-responsiveness.

M. Baumann, M. Tatagiba, D. Zips, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Translational research in radiotherapy - getting closer to the bedside.

M. Baumann, J. Overgaard, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Recovery from sublethal damage during fractionated irradiation of human FaDu SCC.

M. Krause, M. Baumann, H. Thames, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Regional radiotherapy in high-risk breast cancer: is the issue solved?

M. Krause, M. Baumann, B. Offersen, 2015, The British journal of radiology.

Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapy

D. Aust, S. Löck, M. Krause, 2018, PloS one.

2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography in target volume definition for radiotherapy of patients with non-small-cell lung cancer.

C. Rübe, M. Baumann, U. Nestle, 2002, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy

S. Löck, M. Baumann, D. Zips, 2017, Clinical and translational radiation oncology.

Can Local Ablative Radiotherapy Revert Castration-resistant Prostate Cancer to an Earlier Stage of Disease?

M. Wirth, S. Löck, M. Krause, 2019, European urology.

Prostatakarzinom: Kurative Therapie

M. Baumann, M. Wirth, M. Fröhner, 2016 .

Medical Thoracoscopy: Therapy for Benign Conditions

M. Baumann, 2004 .

A number of bone marrow mesenchymal stem cells but neither phenotype nor differentiation capacities changes with age of rats.

M. Baumann, S. Tokalov, N. Abolmaali, 2007, Molecules and cells.

M. Baumann, S. Tokalov, N. Abolmaali, 2007, Stem cells and development.

Haemoglobin and creatinine values as prognostic factors for outcome of concurrent radiochemotherapy in locally advanced head and neck cancers

P. Wust, V. Budach, M. Baumann, 2016, Strahlentherapie und Onkologie.

Enhanced susceptibility of irradiated tumor vessels to vascular endothelial growth factor receptor tyrosine kinase inhibition.

M. Baumann, H. Thames, D. Zips, 2005, Cancer research.

Comparison of early pulmonary changes in 18FDG-PET and CT after combined radiochemotherapy for advanced non-small-cell lung cancer: a study in 15 patients.

C. Rübe, M. Baumann, U. Nestle, 2002, Frontiers of radiation therapy and oncology.

Generation of biological hypotheses by functional imaging links tumor hypoxia to radiation induced tissue inflammation/glucose uptake in head and neck cancer.

S. Löck, M. Krause, M. Baumann, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Increased FDG uptake on late-treatment PET in non-tumour-affected oesophagus is prognostic for pathological complete response and disease recurrence in patients undergoing neoadjuvant radiochemotherapy

F. Hofheinz, J. Weitz, S. Löck, 2017, European Journal of Nuclear Medicine and Molecular Imaging.

Heat shock protein 70 and tumor‐infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK‐ROG)

V. Budach, J. Debus, A. Abdollahi, 2017, International journal of cancer.

Hyperfractionated accelerated radiation therapy (HART) of 70.6 Gy with concurrent 5-FU/Mitomycin C is superior to HART of 77.6 Gy alone in locally advanced head and neck cancer: long-term results of the ARO 95-06 randomized phase III trial.

S. Marnitz, V. Budach, K. Wernecke, 2015, International journal of radiation oncology, biology, physics.

MRI-guided Radiation Therapy: An Emerging Paradigm in Adaptive Radiation Oncology.

P. Lambin, H. Hricak, M. Ladd, 2020, Radiology.

Comparable radiation response of ex vivo and in vivo irradiated tumor samples determined by residual γH2AX.

S. Löck, M. Krause, M. Baumann, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Clinically important factors modifying the response of tumors and normal tissue to radiation therapy.

M. Baumann, A. Krüll, R. Schwarz, 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Modeling tumor control probability for spatially inhomogeneous risk of failure based on clinical outcome data.

A. Lühr, S. Löck, A. Jakobi, 2017, Zeitschrift fur medizinische Physik.

Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy.

M. Krause, M. Baumann, H. Thames, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radioresistance of K-Ras mutated human tumor cells is mediated through EGFR-dependent activation of PI3K-AKT pathway.

M. Baumann, K. Dittmann, H. Rodemann, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Antiproliferative effects of EGFR tyrosine kinase inhibition and radiation-induced genotoxic injury are attenuated by adhesion to fibronectin.

M. Baumann, N. Cordes, V. Sandfort, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiotherapy of lung cancer: technology meets biology meets multidisciplinarity.

M. Baumann, D. Zips, S. Appold, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

New anticancer agents: in vitro and in vivo evaluation.

M. Baumann, H. Thames, D. Zips, 2005, In vivo.

Decreased repopulation as well as increased reoxygenation contribute to the improvement in local control after targeting of the EGFR by C225 during fractionated irradiation.

M. Krause, M. Baumann, H. Thames, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Re‐irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score—report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK)

V. Budach, J. Debus, M. Krause, 2018, Cancer medicine.

BAY 87–2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts

M. Baumann, D. Zips, A. Yaromina, 2014, Radiation oncology.

Hypoxia-inducible factor pathway inhibition resolves tumor hypoxia and improves local tumor control after single-dose irradiation.

M. Baumann, D. Zips, M. Pruschy, 2014, International journal of radiation oncology, biology, physics.

Effect of combined irradiation and EGFR/Erb-B inhibition with BIBW 2992 on proliferation and tumour cure in cell lines and xenografts

M. Krause, M. Baumann, D. Zips, 2014, Radiation oncology.

Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression.

M. Krause, M. Baumann, H. Thames, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Pharmacological inhibition of EGFR tyrosine kinase affects ILK-mediated cellular radiosensitization in vitro

M. Baumann, N. Cordes, V. Sandfort, 2007, International journal of radiation biology.

Cellular and molecular properties of 90Y-labeled cetuximab in combination with radiotherapy on human tumor cells in vitro

J. Steinbach, M. Baumann, H. Rodemann, 2012, Strahlentherapie und Onkologie.

Global Task Force on Radiotherapy for Cancer Control.

B. Vikram, D. Jaffray, R. Atun, 2015, The Lancet. Oncology.

Radiation therapy and the global health agenda.

B. Vikram, D. Jaffray, R. Atun, 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results.

M. Krause, M. Baumann, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Inactivation of HNSCC Cells by 90Y-Labeled Cetuximab Strictly Depends on the Number of Induced DNA Double-Strand Breaks

J. Steinbach, M. Baumann, R. Grenman, 2013, The Journal of Nuclear Medicine.

Cellular and tumor radiosensitivity is correlated to epidermal growth factor receptor protein expression level in tumors without EGFR amplification.

M. Krause, M. Baumann, R. Grenman, 2011, International journal of radiation oncology, biology, physics.

Keynote comment: Radiotherapy in the age of molecular oncology.

M. Baumann, 2006, The Lancet. Oncology.

Impact of adjuvant inhibition of vascular endothelial growth factor receptor tyrosine kinases on tumor growth delay and local tumor control after fractionated irradiation in human squamous cell carcinomas in nude mice.

M. Krause, M. Baumann, H. Thames, 2005, International journal of radiation oncology, biology, physics.

Ultrafractionation in human malignant glioma xenografts

M. Krause, M. Baumann, M. Joiner, 2003, International journal of cancer.

In regard to Solomon et al.: EGFR blockade with ZD1839 ("Iressa") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma. IJROBP 2003;55:713-723.

M. Krause, M. Baumann, H. Thames, 2003, International journal of radiation oncology, biology, physics.

Vertebral fractures - An underestimated side-effect in patients treated with radio(chemo)therapy.

M. Baumann, A. Hoffmann, E. Troost, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Development and validation of NTCP models for acute side-effects resulting from proton beam therapy of brain tumours.

H. Shih, A. Lühr, S. Löck, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Sample-size calculation for preclinical dose-response experiments using heterogeneous tumour models.

S. Löck, M. Krause, M. Baumann, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiotherapy enhances uptake and efficacy of 90Y-Cetuximab: a preclinical trial.

J. Steinbach, M. Andreeff, S. Löck, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Comparison of GeneChip, nCounter and real-time polymerase chain reaction based gene expressions predicting loco-regional tumour control after primary and postoperative radiochemotherapy in head and neck squamous cell carcinoma.

V. Budach, F. Buchholz, J. Debus, 2020, The Journal of molecular diagnostics : JMD.

Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy.

D. Aust, J. Steinbach, F. Buchholz, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radioresistance of KRAS/TP53‐mutated lung cancer can be overcome by radiation dose escalation or EGFR tyrosine kinase inhibition in vivo

C. Benes, M. Krause, M. Baumann, 2020, International journal of cancer.

FMISO-PET-based lymph node hypoxia adds to the prognostic value of tumor only hypoxia in HNSCC patients.

J. Steinbach, S. Löck, M. Krause, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-term quality of life in inoperable non-small cell lung cancer patients treated with conventionally fractionated compared to hyperfractionated accelerated radiotherapy - Results of the randomized CHARTWEL trial.

M. Krause, M. Baumann, J. König, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy.

V. Budach, J. Debus, A. Abdollahi, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Research Facility for Radiobiological Studies at the University Proton Therapy Dresden.

A. Lühr, S. Helmbrecht, M. Krause, 2018, International journal of particle therapy.

FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy.

S. Leger, S. Löck, M. Krause, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

EGFR-amplification plus gene expression profiling predicts response to combined radiotherapy with EGFR-inhibition: A preclinical trial in 10 HNSCC-tumour-xenograft models.

S. Löck, M. Krause, M. Baumann, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Tumor heterogeneity determined with a γH2AX foci assay: A study in human head and neck squamous cell carcinoma (hHNSCC) models.

S. Löck, M. Krause, M. Baumann, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Exploratory study of the prognostic value of microenvironmental parameters during fractionated irradiation in human squamous cell carcinoma xenografts.

M. Baumann, H. Thames, D. Zips, 2011, International journal of radiation oncology, biology, physics.

Residual γH2AX foci predict local tumour control after radiotherapy.

M. Krause, M. Baumann, H. Thames, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma

M. Baumann, L. Kunz-Schughart, A. Dubrovska, 2015, Oncotarget.

Radiotherapy in small cell lung cancer: limited volumes in limited disease and adding thoracic radiotherapy in extended disease?

M. Baumann, L. Kepka, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The future of IGRT – Cost Benefit Analysis

M. Baumann, D. Zips, T. Hölscher, 2008, Acta oncologica.

Splicing Mutations in TP53 in Human Squamous Cell Carcinoma Lines Influence Immunohistochemical Detection

M. Baumann, D. Zips, R. Grenman, 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection

A. Walch, V. Budach, J. Debus, 2018, Clinical Cancer Research.

Sustained elevation of NF‐κB DNA binding activity in radiation‐induced lung damage in rats

M. Baumann, G. Baretton, H. Alheit, 2003, International journal of radiation biology.

Towards a Cancer Mission in Horizon Europe

D. Hanahan, D. Lacombe, A. Berns, 2019, Molecular oncology.

Clonogens and cancer stem cells

M. Krause, M. Baumann, R. Hill, 2008, Nature Reviews Cancer.

Tumor DNA‐methylome derived epigenetic fingerprint identifies HPV‐negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy

W. Weichert, V. Budach, A. Abdollahi, 2021, International journal of cancer.

Tumour-infiltrating CD11b+ myelomonocytes and response to fractionated irradiation of human squamous cell carcinoma (hSCC) xenografts.

M. Baumann, D. Zips, A. Yaromina, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiation-induced lung damage - Clinical risk profiles and predictive imaging on their way to risk-adapted individualized treatment planning?

M. Baumann, E. Troost, N. Ebert, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cytotoxic properties of radionuclide-conjugated Cetuximab without and in combination with external irradiation in head and neck cancer cells in vitro

J. Steinbach, M. Baumann, R. Freudenberg, 2014, International journal of radiation biology.

Simultaneous PLK1 inhibition improves local tumour control after fractionated irradiation.

M. Krause, M. Baumann, L. Kunz-Schughart, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Linear-quadratic analysis of tumor response to fractionated radiotherapy: a study on human squamous cell carcinoma xenografts

M. Baumann, H. Dubben, C. Petersen, 1998, Strahlentherapie und Onkologie.

[A linear quadratic analysis of the effect of different fractionation patterns on local tumor control: a study on human squamous-cell carcinomas in nude mice].

M. Baumann, H. Dubben, C. Petersen, 1998, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Linear-quadratic analysis of tumour response to fractionated radiotherapy: a study on human squamous cell carcinoma xenografts.

M. Baumann, H. Dubben, C. Petersen, 1998 .

Monitoring PAI-1 and VEGF levels in 6 human squamous cell carcinoma xenografts during fractionated irradiation.

M. Molls, M. Baumann, D. Zips, 2012, International journal of radiation oncology, biology, physics.

Triple angiokinase inhibition, tumour hypoxia and radiation response of FaDu human squamous cell carcinomas.

M. Baumann, D. Zips, F. Hilberg, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiobiological hypoxia, oxygen tension, interstitial fluid pressure and relative viable tumour area in two human squamous cell carcinomas in nude mice during fractionated radiotherapy.

B. Beuthien-Baumann, W. Enghardt, M. Baumann, 2001, Acta oncologica.

Thyroid Lymphoma

M. Baumann, H. Chin, R. Crowell, 2013 .

Effects of three modifiers of glycolysis on ATP, lactate, hypoxia, and growth in human tumor cell lines in vivo

M. Baumann, D. Zips, L. Kunz-Schughart, 2012, Strahlentherapie und Onkologie.

Correlation of FMISO simulations with pimonidazole-stained tumor xenografts: A question of O2 consumption?

M. Baumann, D. Mönnich, D. Zips, 2016, Medical physics.

[The therapeutic management of radiogenic oral mucositis].

M. Baumann, W. Dörr, T. Herrmann, 1997, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radio-chemotherapy.

F. Hofheinz, V. Grégoire, S. Löck, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell line HCT-116.

T. Ried, M. Baumann, L. Kunz-Schughart, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Rat model of lung fibrosis: comparison of functional, biochemical, and histopathological changes 4 months after single irradiation of the right hemithorax.

M. Baumann, J. Pauluhn, M. Rosenbruch, 2001, Toxicology.

Results of a randomized controlled phase III trial: efficacy of polyphenol-containing cystus® tea mouthwash solution for the reduction of mucositis in head and neck cancer patients undergoing external beam radiotherapy

S. Löck, M. Krause, M. Baumann, 2020, Strahlentherapie und Onkologie.

Effect of the Hypoxic Cell Sensitizer Isometronidazole on Local Control of Two Human Squamous Cell Carcinomas after Fractionated Irradiation

B. Beuthien-Baumann, M. Krause, M. Baumann, 2004, Strahlentherapie und Onkologie.

[What do we know about the mechanisms of the time factor in oncological therapy?].

M. Baumann, C. Petersen, 2000, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Dose-volume predictors of early esophageal toxicity in non-small cell lung cancer patients treated with accelerated-hyperfractionated radiotherapy.

S. Löck, M. Krause, M. Baumann, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy

V. Budach, J. Debus, A. Abdollahi, 2017, Clinical and translational radiation oncology.

Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German

P. Wust, V. Budach, K. Wernecke, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Setting up an interdisciplinary cancer center between the poles of internal and external interests].

M. Baumann, G. Ehninger, M. Simon, 2007, Zeitschrift fur arztliche Fortbildung und Qualitatssicherung.

[Comparison of various fractionation schedule in curative radiotherapy alone of locally advanced head and neck tumors].

M. Baumann, H. T. Klages, 2001, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Towards equity in turbulent Europe ESTRO, European cooperation and the European Commission.

M. Baumann, M. Brada, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Combined radiotherapy and chemotherapy

V. Grégoire, J. Machiels, M. Baumann, 2009, Basic Clinical Radiobiology.

Accelerated chemoradiation to 70.6 GY is more effective than accelerated radiation to 77.6 GY alone-two years results of a German multicentre randomized trial

P. Wust, V. Budach, H. Sack, 2000 .

Reproducibility of target coverage in stereotactic spot scanning proton lung irradiation under high frequency jet ventilation.

W. Mühlnickel, W. Enghardt, M. Baumann, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The Impact of Cell-Cell Contact, E-Cadherin and EGF Receptor on the Cellular Radiosensitivity of A431 Cancer Cells

M. Baumann, V. Valentini, S. Hehlgans, 2012, Radiation research.

Radiochemotherapy is more effective than dose escalation in locally advanced head and neck cancer: results of a german multicentre randomized trial

V. Budach, K. Wernecke, M. Baumann, 2001 .

Lack of effect of small high-dose volumes on the dose-response relationship for the development of fibrosis in distant parts of the ipsilateral lung in mini-pigs.

M. Baumann, S. Appold, T. Herrmann, 2000, International journal of radiation biology.

Effects of high-dose radiotherapy to tumors of the pituitary on the optic chiasm.

T. Seiler, M. Baumann, H. Alheit, 1999, Frontiers of radiation therapy and oncology.

Effect of irradiated volume on lung damage in pigs.

M. Baumann, T. Herrmann, A. Knorr, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Fractionation effect on radiation-induced growth retardation of tibia in rabbits and rats.

M. Baumann, H. Thames, H. Alheit, 1998, Acta oncologica.

Radiosensivity of Tumor Cells: The Predictive Value of SF2

A. Taghian, M. Baumann, W. Budach, 1993 .

Overestimation of grey matter atrophy in glioblastoma patients following radio(chemo)therapy

J. van den Hoff, B. Beuthien-Baumann, M. Baumann, 2021, Magnetic Resonance Materials in Physics, Biology and Medicine.

Photon vs. proton radiochemotherapy: Effects on brain tissue volume and perfusion.

Mechthild Krause, Michael Baumann, Esther G C Troost, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Molecular radiation biology/oncology at its best: cutting edge research presented at the 13th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology.

M. Baumann, J. Overgaard, B. Wouters, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms.

Mechthild Krause, Michael Baumann, Ulla Kasten-Pisula, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.

R. Arriagada, J. Pignon, S. Mandrekar, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

FLASH radiotherapy International Workshop.

J. Bourhis, M. Baumann, R. Coppes, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials

C. N. Coleman, M. Dewhirst, C. Coleman, 2016, Clinical Cancer Research.

Expanding global access to radiotherapy.

Michael Baumann, Brian O'Sullivan, Yolande Lievens, 2015, The Lancet. Oncology.

Cancer stem cells at the crossroads of current cancer therapy failures--radiation oncology perspective.

M. Krause, M. Baumann, U. Koch, 2010, Seminars in cancer biology.

CD8+ tumour‐infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK‐ROG)

Mechthild Krause, Michael Baumann, Christine Bayer, 2016, International journal of cancer.

Impact of Endogenous and Exogenous Factors on Radiation Sequelae

M. Baumann, 1995 .

Tumor Biology’s Impact on Clinical Cure Rates

M. Krause, M. Baumann, 2009 .

Hyperbaric oxygen therapy in the treatment of radio-induced lesions in normal tissues: a literature review.

D. Mathieu, M. Baumann, S. Dische, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Present results of neutron therapy. The German experience.

M. Baumann, R. Schmidt, A. Krüll, 1994, Acta oncologica.

Establishment of technical prerequisites for cell irradiation experiments with laser-accelerated electrons.

W. Enghardt, M. Baumann, R. Sauerbrey, 2010, Medical physics.

Experimental study on different combination schedules of VEGF-receptor inhibitor PTK787/ZK222584 and fractionated irradiation.

Mechthild Krause, Michael Baumann, Daniel Zips, 2003, Anticancer research.

Preclinical In Vivo Evaluation of Novel Radiosensitizers by Local Tumor Control Experiments

M. Baumann, I. Kurth, Karolin Schneider, 2020 .

Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group

P. A. Gardner, A. Caraceni, S. Boriani, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

First clinical application of a prompt gamma based in vivo proton range verification system.

Carlo Fiorini, Wolfgang Enghardt, Michael Baumann, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Heterogeneity of tumour response to combined radiotherapy and EGFR inhibitors: Differences between antibodies and TK inhibitors

M. Krause, M. Baumann, Y. Deuse, 2009, International journal of radiation biology.

Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG

D. Aust, V. Budach, F. Buchholz, 2016, Clinical Cancer Research.

Subjugation of TGFβ Signaling by Human Papilloma Virus in Head and Neck Squamous Cell Carcinoma Shifts DNA Repair from Homologous Recombination to Alternative End Joining

J. Murnane, M. Baumann, M. Barcellos-Hoff, 2018, Clinical Cancer Research.

Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme

S. Löck, M. Krause, M. Baumann, 2015, Radiation oncology.

Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments☆

Mechthild Krause, Michael Baumann, Anna Dubrovska, 2017, Advanced drug delivery reviews.

Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.

V. Budach, J. Debus, A. Abdollahi, 2019, European journal of cancer.

Low-dose hyperradiosensitivity of human glioblastoma cell lines in vitro does not translate into improved outcome of ultrafractionated radiotherapy in vivo

Benjamin Georgi, Mechthild Krause, Michael Baumann, 2005, International journal of radiation biology.

Cell heterogeneity and subpopulations in solid tumors characterized by simultaneous immunophenotyping and DNA content analysis.

N. Willich, M. Baumann, A. Schuck, 2000, Cytometry.

Ultrafractionation in A7 human malignant glioma in nude mice

M. Krause, M. Baumann, D. Zips, 2003, International journal of radiation biology.

Metastases after fractionated radiation therapy of three murine tumor models.

M. Baumann, H. Suit, R. Sedlacek, 1990, International journal of radiation oncology, biology, physics.

Cancer stem cells in radiation response: current views and future perspectives in radiation oncology

M. Baumann, A. Dubrovska, C. Peitzsch, 2019, International journal of radiation biology.

Residual gammaH2AX foci in head and neck squamous cell carcinomas as predictors for tumour radiosensitivity: Evaluation in pre-clinical xenograft models and clinical specimens.

S. Löck, M. Krause, M. Baumann, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Combined treatment of the immunoconjugate bivatuzumab mertansine and fractionated irradiation improves local tumour control in vivo.

M. Krause, M. Baumann, K. Heider, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Molecular targeting in radiotherapy of lung cancer.

M. Krause, M. Baumann, D. Zips, 2004, Lung cancer.

Pre-clinical imaging for establishment and comparison of orthotopic non-small cell lung carcinoma: in search for models reflecting clinical scenarios.

Antje Dietrich, Steffen Löck, Mechthild Krause, 2019, The British journal of radiology.

Inactivation of AP1 Proteins by a Nuclear Serine Protease Precedes the Onset of Radiation-Induced Fibrosing Alveolitis1

M. Baumann, G. Baretton, M. Haase, 2008, Radiation research.

Impact of Hypoxia and the Metabolic Microenvironment on Radiotherapy of Solid Tumors

A. Haase, O. Thews, M. Baumann, 2004, Strahlentherapie und Onkologie.

Prediction of clonogenic cell survival curves based on the number of residual DNA double strand breaks measured by γH2AX staining

B. Beuthien-Baumann, M. Krause, M. Baumann, 2009, International journal of radiation biology.

Supplemental Data PINCH 1 controls Akt 1 for regulating radiation sensitivity by inhibiting PP 1 α

C. Pilarsky, A. Shevchenko, M. Baumann, 2010 .

Aberrant overexpression of miR-421 downregulates ATM and leads to a pronounced DSB repair defect and clinical hypersensitivity in SKX squamous cell carcinoma.

T. Dörk, N. Bogdanova, M. Baumann, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cancer stem cells as a predictive factor in radiotherapy.

M. Baumann, T. Brunner, L. Kunz-Schughart, 2012, Seminars in radiation oncology.

EGFR-mediated chromatin condensation protects KRAS-mutant cancer cells against ionizing radiation.

Patricia Greninger, J. Settleman, C. Benes, 2014, Cancer research.

EGF receptor inhibition radiosensitizes NSCLC cells by inducing senescence in cells sustaining DNA double-strand breaks.

J. Settleman, C. Benes, M. Krause, 2011, Cancer research.

Therapeutics , Targets , and Chemical Biology EGF Receptor Inhibition Radiosensitizes NSCLC Cells by Inducing Senescence in Cells SustainingDNADouble-Strand Breaks

J. Settleman, C. Benes, M. Krause, 2011 .

Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor model

M. Krause, M. Baumann, R. Bergmann, 2017, Oncoimmunology.

Personalized Radiation Oncology: Epidermal Growth Factor Receptor and Other Receptor Tyrosine Kinase Inhibitors.

M. Krause, M. Baumann, W. Mckenna, 2016, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Response of U87 glioma xenografts treated with concurrent rapamycin and fractionated radiotherapy: possible role for thrombosis.

P. Lambin, M. Krause, M. Baumann, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

β₁Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy.

A. Shevchenko, M. Krause, M. Baumann, 2012, The Journal of clinical investigation.

Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrest.

M. Krause, M. Baumann, T. Grob, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin-EGFR Pathway.

R. Mak, L. Sequist, C. Benes, 2017, Cancer research.

Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas

M. Krause, M. Baumann, A. Linge, 2021, Cancers.

Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.

W. Weichert, J. Debus, A. Abdollahi, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Connective tissue growth factor (CTGF) methylation status is associated with prognosis of patients with head and neck squamous cell carcinoma (HNSCC) treated with radiochemotherapy (RCHT): A multicenter study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

J. Debus, V. Budach, A. Abdollahi, 2019, Journal of Clinical Oncology.

What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyond

M. Baumann, J. Overgaard, I. Kurth, 2020, Molecular oncology.

The Role of Cancer Stem Cells in Tumour Radioresponse

M. Krause, M. Baumann, A. Linge, 2016 .

Potential clinical predictors of outcome after postoperative radiotherapy of non-small cell lung cancer

S. Löck, M. Krause, M. Baumann, 2014, Strahlentherapie und Onkologie.

Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma

G. Schackert, S. Löck, M. Krause, 2020, Cancers.

Discovery of the cancer stem cell related determinants of radioresistance.

M. Baumann, L. Kunz-Schughart, A. Dubrovska, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells.

M. Wirth, M. Krause, M. Baumann, 2015, Cancer research.

Rapid re-expression of CD133 protein in colorectal cancer cell lines in vitro and in vivo

T. Ried, M. Baumann, L. Kunz-Schughart, 2012, Laboratory Investigation.

GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy

A. Abdollahi, S. Löck, M. Krause, 2021, bioRxiv.

An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells.

E. Schröck, B. Klink, M. Wirth, 2016, Cancer research.

The Role of Cancer Stem Cells in Tumor Radioresistance

M. Baumann, A. Dubrovska, C. Peitzsch, 2014 .

Flow cytometric determination of the time of metastasis during fractionated radiation therapy of the rat rhabdomyosarcoma R1H.

M. Baumann, H. Beck-Bornholdt, H. Vogler, 1990, International journal of radiation biology.

Impact of the adaptor protein GIPC1/Synectin on radioresistance and survival after irradiation of prostate cancer

M. Krause, M. Baumann, S. Hehlgans, 2012, Strahlentherapie und Onkologie.

Bridging the valley of death: The new Radiotherapy & Oncology section "First in man - Translational innovations in radiation oncology".

M. Baumann, J. Overgaard, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L

S. Löck, M. Krause, M. Baumann, 2021, Oncogene.

Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology.

J. Sarkaria, K. Camphausen, P. Choyke, 2018, The Lancet. Oncology.

Langerhans cell histiocytosis with central nervous system involvement—complete response to 2‐chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinib

M. Baumann, T. Cerny, D. Koeberle, 2012, Hematological oncology.

Clinical biomarkers of kinase activity: examples from EGFR inhibition trials

M. Krause, M. Baumann, 2008, Cancer and Metastasis Reviews.

PAI-1 levels predict response to fractionated irradiation in 10 human squamous cell carcinoma lines of the head and neck.

M. Molls, M. Baumann, F. Sweep, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Evaluation of response using FDG-PET/CT and diffusion weighted MRI after radiochemotherapy of pancreatic cancer: a non-randomized, monocentric phase II clinical trial—PaCa-DD-041 (Eudra-CT 2009-011968-11)

R. Grützmann, J. Weitz, M. Baumann, 2020, Strahlentherapie und Onkologie.

Blockage of Epidermal Growth Factor Receptor-Phosphatidylinositol 3-Kinase-AKT Signaling Increases Radiosensitivity of K-RAS Mutated Human Tumor Cells In vitro by Affecting DNA Repair

Shaomeng Wang, M. Baumann, K. Dittmann, 2006, Clinical Cancer Research.

Blockage of Epidermal Growth Factor Receptor-Phosphatidylinositol 3-Kinase-AKT Signaling Increases Radiosensitivity of KRAS Mutated HumanTumor Cells In vitro byAffecting

M. Baumann, K. Dittmann, H. Rodemann, 2006 .

[Radiotherapy of solitary and multiple eosinophilic granulomas of bone (stage I)].

T. Wiegel, M. Baumann, J. Knop, 1991, Strahlentherapie und Onkologie (Print).

Potential of a Cetuximab‐based radioimmunotherapy combined with external irradiation manifests in a 3‐D cell assay

J. Steinbach, M. Baumann, R. Freudenberg, 2014, International Journal of Cancer.

Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer

M. Baumann, A. Schreiber, N. Abolmaali, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell lines HCT-116.

T. Ried, M. Baumann, L. Kunz-Schughart, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Adjuvant inhibition of the epidermal growth factor receptor after fractionated irradiation of FaDu human squamous cell carcinoma.

M. Krause, M. Baumann, D. Zips, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Impact of preirradiation of the tumour bed on cell production rate and cell loss of human FaDu squamous cell carcinoma growing in nude mice.

M. Baumann, D. Zips, H. Baisch, 1999, International Journal of Radiation Biology.

Impact of tumor stroma on expression of the tumor bed effect in R1H rat rhabdomyosarcoma.

M. Baumann, H. Beck-Bornholdt, F. Würschmidt, 1994, Radiation research.

Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS.

M. Baumann, K. Dittmann, H. Rodemann, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Usefulness of dynamic contrast enhanced computed tomography in patients with non-small-cell lung cancer scheduled for radiation therapy.

M. Baumann, S. Tokalov, N. Abolmaali, 2010, Lung cancer.

ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy

V. Budach, J. Debus, A. Abdollahi, 2020, The Pharmacogenomics Journal.

Molecular radiation biology/oncology.

M. Baumann, H. Rodemann, E. Dikomey, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Editorial Molecular radiation biology/oncology

M. Baumann, H. Rodemann, E. Dikomey, 2004 .

Epidermal growth factor receptor inhibitors for radiotherapy: biological rationale and preclinical results

M. Krause, M. Baumann, D. Zips, 2008, The Journal of pharmacy and pharmacology.

Final Results of the Prospective Biomarker Trial PETra: [11C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma

J. van den Hoff, J. Steinbach, B. Beuthien-Baumann, 2020, Clinical Cancer Research.

German Cancer Consortium (DKTK) – A national consortium for translational cancer research

W. Hiddemann, W. Wick, M. Krause, 2019, Molecular oncology.

Towards a cancer mission in Horizon Europe: recommendations

D. Hanahan, R. Bernards, H. Adami, 2020, Molecular oncology.

Screening and Validation of Molecular Targeted Radiosensitizers.

Christopher J. Ott, Steven H. Lin, Patricia Greninger, 2021, International journal of radiation oncology, biology, physics.

Heterogeneity of γH2AX Foci Increases in Ex Vivo Biopsies Relative to In Vivo Tumors

S. Löck, M. Krause, M. Baumann, 2018, International journal of molecular sciences.

Serial FDG-PET on patients with head and neck cancer: Implications for radiation therapy

M. Baumann, A. Schreiber, N. Abolmaali, 2009, International journal of radiation biology.

Clinical perspectives of cancer stem cell research in radiation oncology.

M. Baumann, A. Dubrovska, R. Bütof, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

"Radiobiology of Proton Therapy": Results of an international expert workshop.

B. S. Sørensen, T. Bortfeld, R. Mohan, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

PRONTOX – proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial

Steffen Löck, Mechthild Krause, Michael Baumann, 2016, Trials.

[The efficacy of radiotherapy in vertebral hemangiomas].

M. Baumann, T. Herrmann, C. Winkler, 1996, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy †

J. Steinbach, M. Krause, M. Baumann, 2014, Pharmaceuticals.

The PD‐1/PD‐L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK‐ROG)

V. Budach, J. Debus, A. Abdollahi, 2017, International journal of cancer.

Neurocognitive function and quality of life after proton beam therapy for brain tumour patients.

A. Lühr, S. Löck, M. Krause, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Residual DNA double strand breaks in perfused but not in unperfused areas determine different radiosensitivity of tumours.

M. Krause, M. Baumann, H. Thames, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Differentiation status of human squamous cell carcinoma xenografts does not appear to correlate with the repopulation capacity of clonogenic tumour cells during fractionated irradiation

M. Krause, M. Baumann, H. Thames, 2004, International journal of radiation biology.

Union of light ion therapy centers in Europe (ULICE EC FP7) - Objectives and achievements of joint research activities.

R. Pötter, D. Georg, J. Debus, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Reirradiation after radiotherapy of primary brain tumors.

M. Baumann, W. Dörr, C. Winkler, 1999, Frontiers of radiation therapy and oncology.

Adoptive transfer of cytotoxic T-cells for treatment of residual disease after irradiation

E. Rieber, M. Krause, M. Baumann, 2007, International journal of radiation biology.

Towards clinical evidence in particle therapy: ENLIGHT, PARTNER, ULICE and beyond

M. Durante, J. Debus, U. Amaldi, 2013, Journal of radiation research.

Predictive factors in radiotherapy for non-small cell lung cancer: present status.

N Zamboglou, S Senan, N. Choi, 2001, Lung cancer.

Clinical trials for personalized glioblastoma radiotherapy: Markers for efficacy and late toxicity but often delayed treatment - Does that matter?

M. Krause, M. Baumann, A. Lattermann, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: A multicenter DKTK/ROG analysis.

A. Boulesteix, V. Budach, J. Debus, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Time in radiation oncology - keep it short!

M. Baumann, R. Bütof, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Effect of cetuximab and fractionated irradiation on tumour micro-environment.

J. Bussink, B. Beuthien-Baumann, M. Krause, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Stimulated PI3K-AKT Signaling Mediated through Ligand or Radiation-Induced EGFR Depends Indirectly, but not Directly, on Constitutive K-Ras Activity

Michael Baumann, M. Baumann, H. Rodemann, 2007, Molecular Cancer Research.

Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC.

V. Budach, F. Buchholz, J. Debus, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Selective inhibition of the epidermal growth factor receptor tyrosine kinase by BIBX1382BS and the improvement of growth delay, but not local control, after fractionated irradiation in human FaDu squamous cell carcinoma in the nude mouse

M. Krause, M. Baumann, D. Zips, 2003, International journal of radiation biology.

[Radiation tolerance of the human spinal cord].

V. Budach, M. Baumann, S. Appold, 1994, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Anti-VEGF Strategies in Combination with Radiotherapy

M. Baumann, D. Zips, 2003 .

Establishment of a small animal tumour model for in vivo studies with low energy laser accelerated particles

M. Krause, M. Baumann, J. Pawelke, 2014, Radiation Oncology.

First report on the patient database for the identification of the genetic pathways involved in patients over-reacting to radiotherapy: GENEPI-II.

R. Bristow, A. Polański, V. Grégoire, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Influence of connective tissue diseases on the expression of radiation side effects: a systematic review.

Michael Baumann, Tobias Hölscher, Søren M Bentzen, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiobiological effectiveness of laser accelerated electrons in comparison to electron beams from a conventional linear accelerator.

Wolfgang Enghardt, Michael Baumann, Christian Richter, 2012, Journal of radiation research.

BAY 87–2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts

M. Baumann, D. Zips, A. Yaromina, 2014, Radiation oncology.

Hyperfractionated radiotherapy in head and neck cancer: a second look at the clinical data.

K. Ang, M. Baumann, S. Bentzen, 1998, Radiotherapy and Oncology.

The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity

A. Abdollahi, B. Klink, S. Löck, 2019, Clinical Cancer Research.

Hyperfractionated radiotherapy: tops or flops?

M. Baumann, H. Beck-Bornholdt, 1999, Medical and pediatric oncology.

HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

D. Aust, V. Budach, F. Buchholz, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Place of proton radiotherapy in future radiotherapy practice.

M. Baumann, D. Zips, 2013, Seminars in radiation oncology.

Modification of staging and treatment of head and neck cancer by FDG-PET/CT prior to radiotherapy

M. Baumann, N. Abolmaali, K. Zöphel, 2013, Strahlentherapie und Onkologie.

Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice.

J. Steinbach, B. Beuthien-Baumann, M. Baumann, 2007, Radiotherapy and Oncology.

Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.

M. Krause, M. Baumann, H. Thames, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

ErbB2 expression through heterodimerization with erbB1 is necessary for ionizing radiation- but not EGF-induced activation of Akt survival pathway.

M. Baumann, H. Rodemann, Jianyong Chen, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cost Effectiveness of Modified Fractionation Radiotherapy versus Conventional Radiotherapy for Unresected Non–Small-Cell Lung Cancer Patients

H. Choy, R. Arriagada, J. Pignon, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Identification of Patient Benefit From Proton Therapy for Advanced Head and Neck Cancer Patients Based on Individual and Subgroup Normal Tissue Complication Probability Analysis.

Steffen Löck, Annika Jakobi, Mechthild Krause, 2015, International journal of radiation oncology, biology, physics.

CD44: A Cancer Stem Cell–Related Biomarker with Predictive Potential for Radiotherapy

Mechthild Krause, Michael Baumann, M. Krause, 2010, Clinical Cancer Research.

2LBA Responding to the cancer crisis: Expanding global access to radiotherapy - a Lancet Oncology Commission

F. Bray, B. Vikram, D. Jaffray, 2015 .

Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC.

M. Krause, M. Baumann, N. Pimentel, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Updated European core curriculum for radiotherapists (radiation oncologists). Recommended curriculum for the specialist training of medical practitioners in radiotherapy (radiation oncology) within Europe.

W. De Neve, M. Baumann, J. Leer, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

New targets for the modulation of radiation response--selective inhibition of the enzyme cyclooxygenase 2.

M. Baumann, C. Petersen, S. Petersen, 2003, Current medicinal chemistry. Anti-cancer agents.

Directly, on Constitutive K-Ras Activity Radiation-Induced EGFR Depends Indirectly, but not Stimulated PI3K-AKT Signaling Mediated through Ligand or

M. Baumann, H. Rodemann, M. Toulany, 2007 .

Stimulated PI 3 K-AKT Signaling Mediated through Ligand or Radiation-Induced EGFR Depends Indirectly , but not Directly , on Constitutive KRas Activity

Michael Baumann, M. Baumann, H. Rodemann, 2007 .

Dose and fractionation concepts in the primary radiotherapy of non-small cell lung cancer.

M. Baumann, D. Zips, S. Appold, 2001, Lung cancer.

Main Session I Dose and fractionation concepts in the primary radiotherapy of non-small cell lung cancer

M. Baumann, D. Zips, S. Appold, 2001 .

Modified Fractionation in the Radical Treatment of Non-Small-Cell Lung Cancer

M. Baumann, D. Zips, U. Nestle, 2000 .

Impact of overall treatment time on local control of slow growing human GL squamous cell carcinoma in nude mice treated by fractionated irradiation.

M. Baumann, H. Baisch, C. Petersen, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Impact of overall treatment time of fractionated irradiation on local control of human FaDu squamous cell carcinoma in nude mice.

T. Wiegel, M. Baumann, H. Baisch, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

PORTAF – postoperative radiotherapy of non-small cell lung cancer: accelerated versus conventional fractionation – study protocol for a randomized controlled trial

S. Löck, M. Krause, M. Baumann, 2017, Trials.

Therapy of localized non-small cell lung cancer (take home messages).

M. Baumann, M. Thomas, G. Stamatis, 2001, Lung Cancer.

Comparison of the Response of human FaDu squamous cell carcinoma in nude mice after hypofractionated-accelerated regimens and “curative” fractionation schedules

M. Baumann, S. Appold, C. Petersen, 1998, Strahlentherapie und Onkologie (Print).

Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC).

V. Budach, R. Dziadziuszko, M. Krause, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Phase III randomised trial Final results of the randomized phase III CHARTWEL-trial ( ARO 97-1 ) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer ( NSCLC )

V. Budach, R. Dziadziuszko, M. Krause, 2011 .

OLI-P: Toxicity and efficacy of local ablative radiotherapy in PSMA-PET staged, oligometastatic prostate cancer—A phase II trial.

M. Wirth, M. Krause, M. Baumann, 2021 .

GTV differentially impacts locoregional control of non-small cell lung cancer (NSCLC) after different fractionation schedules: subgroup analysis of the prospective randomized CHARTWEL trial.

M. Krause, M. Baumann, H. Thames, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Comparison of [18F]FDG uptake and distribution with hypoxia and proliferation in FaDu human squamous cell carcinoma (hSCC) xenografts after single dose irradiation

Michael Baumann, Frank Hofheinz, Bettina Beuthien-Baumann, 2009, International journal of radiation biology.

M. Baumann, D. Zips, A. Yaromina, 2013, Strahlentherapie und Onkologie.

Distribution of 16α-[18F]fluoro-estradiol-3,17β-disulfamate in rats, tumour-bearing mice and piglets

J. Steinbach, P. Brust, M. Baumann, 2002 .

Molecular markers predicting radiotherapy response: report and recommendations from an International Atomic Energy Agency technical meeting.

Michael Baumann, Karin Haustermans, Jolyon H Hendry, 2005, International journal of radiation oncology, biology, physics.

Impact of pre- and early per-treatment FDG-PET based dose-escalation on local tumour control in fractionated irradiated FaDu xenograft tumours.

J. Steinbach, B. Beuthien-Baumann, S. Löck, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy

A. Lühr, S. Löck, A. Jakobi, 2015, Acta oncologica.

EGFR-TK inhibition before radiotherapy reduces tumour volume but does not improve local control: differential response of cancer stem cells and nontumourigenic cells?

M. Krause, M. Baumann, A. Yaromina, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Impact of exogenous lactate on survival and radioresponse of carcinoma cells in vitro

M. Baumann, L. Kunz-Schughart, W. Mueller‐Klieser, 2009, International journal of radiation biology.

A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling

V. Budach, I. Tinhofer, S. Leger, 2017, Scientific Reports.

Combined modality in advanced Hodgkin's disease.

M. Baumann, H. Thames, T. Herrmann, 1998, Journal of Clinical Oncology.

PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro.

M. Baumann, M. Schaller, K. Dittmann, 2008, DNA repair.

Clinical interest in determinations of cellular radiation sensitivity.

H D Suit, S. Skates, M. Baumann, 1989, International journal of radiation biology.

Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy--a retrospective study.

Michael Baumann, Volker Hietschold, Nasreddin Abolmaali, 2012, Lung cancer.

Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.

W. Weichert, V. Budach, J. Debus, 2016, European journal of cancer.

Fractionation in prostate cancer--is it time after all?

M. Baumann, J. Denham, T. Hölscher, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy

V. Budach, F. Buchholz, J. Debus, 2018, Clinical Cancer Research.

Clinical Implementation of Dual-energy CT for Proton Treatment Planning on Pseudo-monoenergetic CT scans.

Wolfgang Enghardt, Mechthild Krause, Michael Baumann, 2017, International journal of radiation oncology, biology, physics.

Modeling in vivo relative biological effectiveness in particle therapy for clinically relevant endpoints

A. Lühr, S. Helmbrecht, M. Krause, 2017, Acta oncologica.

Precise image-guided irradiation of small animals: a flexible non-profit platform

Antje Dietrich, Wolfgang Enghardt, Steffen Löck, 2016, Physics in medicine and biology.

Prognostic value of HIF-1α expression during fractionated irradiation

M. Baumann, H. Thames, D. Zips, 2012, Strahlentherapie und Onkologie.

Prognostic value of HIF-1 alpha expression during fractionated irradiation

M. Baumann, H. Thames, D. Zips, 2012 .

Correlating quantitative MR measurements of standardized tumor lines with histological parameters and tumor control dose.

P. Jakob, M. Baumann, D. Zips, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Dose-controlled irradiation of cancer cells with laser-accelerated proton pulses

W. Enghardt, T. E. Cowan, U. Schramm, 2013 .

The translational research chain: is it delivering the goods?

I. Tannock, M. Baumann, H. Thames, 2001, International journal of radiation oncology, biology, physics.

Accelerated radiation therapy in non-small cell lung cancer.

M. Baumann, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Dual role of ER stress in response to metabolic co-targeting and radiosensitivity in head and neck cancer cells

S. Löck, M. Baumann, B. Kessler, 2020, Cellular and Molecular Life Sciences.

Increase in Tumor Control and Normal Tissue Complication Probabilities in Advanced Head-and-Neck Cancer for Dose-Escalated Intensity-Modulated Photon and Proton Therapy

A. Lühr, S. Löck, A. Jakobi, 2015, Front. Oncol..

Repopulation of moderately well-differentiated and keratinizing GL human squamous cell carcinomas growing in nude mice.

M. Krause, M. Baumann, H. Thames, 2004, International journal of radiation oncology, biology, physics.

Repopulation during fractionated radiotherapy: much has been learned, even more is open

M. Krause, M. Baumann, W. Dörr, 2003, International journal of radiation biology.

No evidence for a different magnitude of the time factor for continuously fractionated irradiation and protocols including gaps in two human squamous cell carcinoma in nude mice.

M. Baumann, D. Zips, A. Schreiber, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Effect of changing the weekly dose intensity of fractionated irradiation on local control of two human squamous cell carcinomas in nude mice.

M. Baumann, A. Schreiber, C. Petersen, 2000, International journal of radiation biology.

Proliferation and micromilieu during fractionated irradiation of human FaDu squamous cell carcinoma in nude mice

M. Krause, M. Baumann, D. Zips, 2003, International journal of radiation biology.

Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation.

M. Krause, M. Baumann, H. Thames, 2001, International journal of radiation oncology, biology, physics.

Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy

F. Buchholz, S. Löck, M. Krause, 2019, Clinical and translational radiation oncology.

Selection of Genetically Distinct, Rapidly Proliferating Clones does not Contribute to Repopulation during Fractionated Irradiation in FaDu Squamous Cell Carcinoma

M. Baumann, D. Zips, W. Eicheler, 2003, Radiation research.

Improving external beam radiotherapy by combination with internal irradiation.

M. Krause, M. Baumann, J. Kotzerke, 2015, The British journal of radiology.

HPV and beyond-looking out for biomarkers for distinguishing the good prognosis from the bad prognosis group in locally advanced and clinically high risk HNSCC.

M. Baumann, F. Lohaus, A. Linge, 2015, Annals of translational medicine.

Mutational patterns of HPV+ and HPV- squamous cell carcinomas of the head and neck (SCCHN) and their interference with outcome after adjuvant chemoradiation: A multicenter biomarker study of the German Cancer Consortium Radiation Oncology Group.

J. Debus, V. Budach, A. Abdollahi, 2015 .

Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes

S. Löck, M. Baumann, F. Lohaus, 2017, Radiation oncology.

Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts

M. Baumann, D. Zips, G. Shakirin, 2009, International journal of radiation biology.

Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice.

M. Baumann, D. Zips, A. Yaromina, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Prolongation of latency or overall treatment time by unplanned radiation pauses. The clinical importance of compensation].

M. Baumann, T. Herrmann, 2005, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Comparison of patient stratification by computed tomography radiomics and hypoxia positron emission tomography in head-and-neck cancer radiotherapy

S. Leger, S. Löck, M. Baumann, 2020, Physics and imaging in radiation oncology.

Glycolytic metabolism and tumour response to fractionated irradiation.

Michael Baumann, Daniel Zips, Ala Yaromina, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Definition and validation of a radiomics signature for loco-regional tumour control in patients with locally advanced head and neck squamous cell carcinoma

I. Tinhofer, S. Leger, S. Löck, 2021 .

Radiotherapy of the rhabdomyosarcoma R1H of the rat: postoperative radiotherapy.

M. Baumann, H. Beck-Bornholdt, U. Carl, 1990, International journal of radiation oncology, biology, physics.

Modelling of late side-effects following cranial proton beam therapy.

H. Shih, A. Lühr, S. Löck, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Response of human squamous cell carcinoma xenografts of different sizes to irradiation: relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units.

M. Baumann, H. Suit, W. Dubois, 1990, Radiation research.

5508 POSTER Efficacy of BIBW 2992, a potent irreversible inhibitor of EGFR and HER2, in models of head and neck cancer

H. Greulich, M. Krause, M. Baumann, 2007 .

Guidelines for equipment and staffing of radiotherapy facilities in the European countries: final results of the ESTRO-HERO survey.

Michael Baumann, Valentin Cernea, Vydmantas Atkocius, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Shaping the future: training of professionals for radiotherapy in Europe.

M. Baumann, J. Leer, C. Verfaillie, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patients

F. Hofheinz, J. Steinbach, S. Löck, 2019, Clinical and translational radiation oncology.

Identification of patient benefit from proton beam therapy in brain tumour patients based on dosimetric and NTCP analyses.

A. Lühr, S. Löck, M. Krause, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potential.

J. Steinbach, M. Krause, M. Baumann, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Core needle biopsies for determination of the microenvironment in individual tumours for longitudinal radiobiological studies.

M. Baumann, H. Thames, D. Zips, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Postoperative concurrent radiochemotherapy versus radiotherapy in high-risk SCCA of the head and neck: Results of the German phase III trial ARO 96-3.

V. Budach, H. Iro, M. Baumann, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stem cells in radiotherapy

M. Krause, M. Baumann, R. Coppes, 2018, Basic Clinical Radiobiology.

Mitomycin-C and 5-Fluoro-Uracil Containing Chemotherapy With Concurrent Hyperfractionated Accelerated RadioTherapy (C-HART) of 70.6 Gy Is More Effective than Dose Escalated HART of 77.6 Gy Alone–10 Year Results of the German Multicenter Phase III Randomized Trial (ARO 95-06)

P. Wust, V. Budach, K. Wernecke, 2007 .

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy

F. Buchholz, S. Löck, M. Krause, 2016, Clinical and translational radiation oncology.

Effects of Lovastatin Alone or Combined with Irradiation on Tumor Cells in Vitro and in Vivo

M. Krause, M. Baumann, A. Yaromina, 2008, Strahlentherapie und Onkologie.

SABR in NSCLC--the beginning of the end or the end of the beginning?

M. Baumann, M. Brada, A. Pope, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

CHARTWEL-Bronchus (ARO 97-1)

M. Baumann, T. Herrmann, R. Koch, 1997, Strahlentherapie und Onkologie.

In vivo imaging in the oral cavity by endoscopic optical coherence tomography

Edmund Koch, Michael Baumann, Christian Schnabel, 2018, Journal of biomedical optics.

Physical and Technical Quality Assurance in the CHARTWEL-Bronchus Trial

M. Baumann, T. Herrmann, N. Hodapp, 2003, Strahlentherapie und Onkologie.

[CHARTWEL-Bronchus (ARO 97-1): a randomized multicenter trial to compare conventional fractionated radiotherapy with CHARTWEL radiotherapy in inoperable non-small-call bronchial carcinoma].

M. Baumann, T. Herrmann, R. Koch, 1997, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse

M. Baumann, D. Zips, W. Eicheler, 2001, International journal of radiation biology.

Local Control as an End Point in Experimental Radiation Therapy of Human Tumor Xenografts

M. Baumann, W. Budach, M. Kleineidam, 1996 .

Quantitative Evaluation of the Effects of Cotransplantation of Heavily Irradiated Human Tumor Cells and of Different Immunosuppressive Measures on the Xenotransplantability of a Human Squamous-Cell Carcinoma into Athymic Nude Mice

M. Baumann, A. Pu, H. Suit, 1992 .

Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)

S. Löck, M. Krause, M. Baumann, 2021, Cancers.

Radiation-induced lung damage: a challenge for radiation biology, experimental and clinical radiotherapy.

M. Baumann, W. Dörr, T. Herrmann, 2000, International journal of radiation biology.

Comparison study of in vivo dose response to laser-driven versus conventional electron beam

M. Krause, M. Baumann, R. Bergmann, 2015, Radiation and Environmental Biophysics.

Establishment of a small animal tumour model for in vivo studies with low energy laser accelerated particles

Mechthild Krause, Michael Baumann, Jörg Pawelke, 2014, Radiation oncology.

Proton radiography for inline treatment planning and positioning verification of small animals

A. Lühr, M. Krause, W. Enghardt, 2017, Acta oncologica.

Combination of EGFR/HER2 Tyrosine Kinase Inhibition by BIBW 2992 and BIBW 2669 with Irradiation in FaDu Human Squamous Cell Carcinoma

M. Krause, M. Baumann, D. Zips, 2007, Strahlentherapie und Onkologie.

Kinetics of EGFR expression during fractionated irradiation varies between different human squamous cell carcinoma lines in nude mice.

M. Krause, M. Baumann, D. Zips, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

TCP and NTCP: a basic introduction.

Michael Baumann, Cordula Petersen, M. Baumann, 2005, Rays.

Impact of increased cell loss on the repopulation rate during fractionated irradiation in human FaDu squamous cell carcinoma growing in nude mice

M. Krause, M. Baumann, H. Thames, 2003, International journal of radiation biology.

Ultrafractionation does not Improve the Results of Radiotherapy in Radioresistant Murine DDL1 Lymphoma

Mechthild Krause, Michael Baumann, Michael C. Joiner, 2005, Strahlentherapie und Onkologie.

Present Status of Computed Tomography for Radiation Therapy Planning

K.-H. Hübener, M. Baumann, M. Baumann, 1992 .

A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling

Steffen Löck, Mechthild Krause, Michael Baumann, 2017, Scientific Reports.

The use of a comprehensive tumour xenograft dataset to validate gene signatures relevant for radiation response.

P. Lambin, M. Starmans, M. Baumann, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Accelerated hyperfractionated radiation therapy to 70.6 Gy plus 5-FU/MMC (C-HART) is more effective than HART to 77.6 Gy alone for locally advanced head and neck cancer. Four-year results of the German ARO 95-6 trial in 384 patients

P. Wust, V. Budach, K. Wernecke, 2003 .

[Recommendations on the therapy of bronchial carcinoma].

L. Freitag, M. Baumann, U. Gatzemeier, 2002, Pneumologie.

Concept for individualized patient allocation: ReCompare—remote comparison of particle and photon treatment plans

A. Lühr, S. Löck, Klaus Roth, 2014, Radiation oncology.

Toward Distributed Conduction of Large-Scale Studies in Radiation Therapy and Oncology: Open-Source System Integration Approach

Uwe Just, Mechthild Krause, Tomas Skripcak, 2016, IEEE Journal of Biomedical and Health Informatics.

Implementation of a software for REmote COMparison of PARticlE and photon treatment plans: ReCompare.

Wolfgang Enghardt, Steffen Löck, Klaus Roth, 2015, Zeitschrift fur medizinische Physik.

V. Budach, J. Debus, A. Abdollahi, 2016, International journal of cancer.

Cost Effectiveness of Modified Fractionation Radiotherapy versus Conventional Radiotherapy for Unresected Non–Small-Cell Lung Cancer Patients

H. Choy, R. Arriagada, J. Pignon, 2013, Journal of Thoracic Oncology.

Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials

C. N. Coleman, M. Dewhirst, M. Baumann, 2016, Clinical Cancer Research.

Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology.

J. Sarkaria, K. Camphausen, P. Choyke, 2018, The Lancet. Oncology.

Fractionation in prostate cancer--is it time after all?

M. Baumann, J. Denham, T. Hölscher, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell lines HCT-116.

T. Ried, M. Baumann, L. Kunz-Schughart, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin-EGFR Pathway.

R. Mak, L. Sequist, C. Benes, 2017, Cancer research.

Re‐irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score—report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK)

V. Budach, J. Debus, M. Krause, 2018, Cancer medicine.

Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma

F. Hofheinz, J. van den Hoff, S. Löck, 2015, The Journal of Nuclear Medicine.

The Lung in Polymyositis and Dermatomyositis

M. Baumann, 1999 .

Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrest.

M. Krause, M. Baumann, T. Grob, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes

Steffen Löck, Michael Baumann, Christian Richter, 2017, Radiation Oncology.

Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.

R. Arriagada, J. Pignon, S. Mandrekar, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Brief preoperative radiotherapy in surgical therapy of rectal carcinoma. Long-term results of a prospective randomized study].

M. Baumann, T. Herrmann, G. Hellmich, 1998, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

Is curative radiation therapy in elderly patients limited by increased normal tissue toxicity?

M. Baumann, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiotherapy of lung cancer: technology meets biology meets multidisciplinarity.

M. Baumann, D. Zips, S. Appold, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Reproducibility of target coverage in stereotactic spot scanning proton lung irradiation under high frequency jet ventilation.

W. Mühlnickel, W. Enghardt, M. Baumann, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Vertebral fractures - An underestimated side-effect in patients treated with radio(chemo)therapy.

M. Baumann, A. Hoffmann, E. Troost, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Molecular targeted agents for enhancing tumour response

V. Grégoire, M. Krause, M. Baumann, 2009, Basic Clinical Radiobiology.

Enhanced susceptibility of irradiated tumor vessels to vascular endothelial growth factor receptor tyrosine kinase inhibition.

M. Baumann, H. Thames, D. Zips, 2005, Cancer research.

Value of functional in-vivo endpoints in preclinical radiation research.

S. Löck, M. Krause, M. Baumann, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Experimental Evaluation of Functional Imaging for Radiotherapy

B. Beuthien-Baumann, M. Krause, M. Baumann, 2007, Strahlentherapie und Onkologie.